EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Safety Evaluation of Repeated Application of Polymeric Microarray Patches in Miniature Pigs

Qonita Kurnia Anjani iD, Aaron R J Hutton, Peter E McKenna, Eneko Larrañeta, Ryan F Donnelly iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202501512 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Qonita Kurnia Anjani und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, BT9 7BL, UK. Hauptthemen laut MEDLINE: Polymers, Drug Delivery Systems, Transdermal Patch. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The safety of repeated microarray patch (MAP) application is crucial for its development as an innovative drug delivery platform. This study is the first to assess the safety of repeated applications of hydrogel‐forming, dissolving, and implantable MAPs over four weeks using miniature pigs, an industry‐standard dermatological model with human‐like skin structure and physiological responses. Uniform MAPs are successfully manufactured, with application forces of 32 N/array resulting in less than 15% needle height reduction. ≈80% of the needle length penetrated Parafilm layers, while 40–60% penetrated excised porcine skin. Repeated MAP applications do not compromise skin barrier function, as confirmed by transepidermal water loss measurements, and caused no adverse skin reactions per modified Draize test results. Systemic safety assessments revealed no significant immune responses, allergic reactions, infections, or inflammatory markers (TNF‐α, IgE, IgG, CRP, and IL‐1β) between day 0 and day 28. No weight loss, infection signs, kidney toxicity, or clinically relevant hematological or biochemical changes are observed. Histopathological evaluations confirmed the absence of lesions or adverse effects. These findings establish the safety of repeated hydrogel‐forming, dissolving, and implantable MAP applications, supporting their potential for safe, effective drug delivery and facilitating their translation from preclinical models to human clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolymersDrug Delivery SystemsTransdermal PatchAnimalsSwine, MiniatureSwineSkinHydrogelsFemale

Stichwörter der Autor:innen

dissolving MAPshydrogel‐forming MAPsimplantable MAPsminiature pigsrepeated applicationsafety

Substanzen

PolymersHydrogels

Autor:innen und Institutionen

  • School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, BT9 7BL, UK.
  • School of Pharmacy and Pharmaceutical Sciences, Ulster University, Pharmacy Building, Cromore Rd, Coleraine, BT52 1SA, UK.

ORCID-Profile: Qonita Kurnia Anjani, Ryan F Donnelly

Zitieren

APA

Anjani, Q. K., Hutton, A. R. J., McKenna, P. E., Larrañeta, E., & Donnelly, R. F. (2025). Safety Evaluation of Repeated Application of Polymeric Microarray Patches in Miniature Pigs. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202501512

Vancouver

Anjani QK, Hutton ARJ, McKenna PE, Larrañeta E, Donnelly RF. Safety Evaluation of Repeated Application of Polymeric Microarray Patches in Miniature Pigs. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202501512

BibTeX
@article{Anjani2025,
  author = {Anjani, Qonita Kurnia and Hutton, Aaron R J and McKenna, Peter E and Larrañeta, Eneko and Donnelly, Ryan F},
  title = {Safety Evaluation of Repeated Application of Polymeric Microarray Patches in Miniature Pigs},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202501512}
}
Kostenlos starten →